# ClinicalTrials.gov record NCT07046819

> PeptideScanner retained ClinicalTrials.gov record NCT07046819 at 2026-08-13T05:54:14.859Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

- Evidence object: `story:clinicaltrials-gov-nct07046819-tirzepatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-12
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07046819-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07046819-tirzepatide-v1.json
- Content SHA-256: `7caeaee0d230ca95b90774106acd30d5423c70c8f584c4efbf6ff049223e41f7`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT07046819 ([`ctg-observation-nct07046819-2026-08-12-5b39883d5ea8`](#source-ctg-observation-nct07046819-2026-08-12-5b39883d5ea8))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07046819 at 2026-08-13T05:54:14.859Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct07046819-2026-08-12-5b39883d5ea8`](#source-ctg-observation-nct07046819-2026-08-12-5b39883d5ea8))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07046819 at 2026-08-13T05:54:14.859Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct07046819-2026-08-12-5b39883d5ea8`](#source-ctg-observation-nct07046819-2026-08-12-5b39883d5ea8))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07046819-2026-08-12-5b39883d5ea8`](#source-ctg-observation-nct07046819-2026-08-12-5b39883d5ea8))

## Sources

<a id="source-ctg-observation-nct07046819-2026-08-12-5b39883d5ea8"></a>
- **ClinicalTrials.gov record NCT07046819 · retained source version 2026-08-12:5b39883d5ea884b5145845563dd0234f104c44b733bea8c8bfe503a0c1058c3b** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07046819) (`ctg-observation-nct07046819-2026-08-12-5b39883d5ea8`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07046819." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07046819-tirzepatide-v1.json SHA-256: 7caeaee0d230ca95b90774106acd30d5423c70c8f584c4efbf6ff049223e41f7.